• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

CVS Health Is Looking Rather Pale Ahead of Earnings

Here's what to avoid for now.
By BRUCE KAMICH
Oct 31, 2022 | 09:45 AM EDT
Stocks quotes in this article: CVS

CVS Health Corp. (CVS) is due to report their latest quarterly figures on Tuesday so this is a good time to check on the health of the charts and indicators.  

 
In our October 7 review of CVS we wrote that "CVS has broken down from a top formation. Expect further declines with a tentative price target of $71. Stand aside." 
 
In this daily bar chart of CVS, below, we can see that prices gapped lower in early October. Trading volume swelled as traders voted with their feet. In the past two weeks prices have drifted higher on reduced volume and formed what I would label a "bear flag" formation. Flags are continuation patterns and I would look for CVS to renew its downward trend.
 
Prices are still below the declining 50-day moving average line and the bearish 200-day line despite the price bounce. The On-Balance-Volume (OBV) line shows us weakness from the middle of August telling us that sellers of CVS are more aggressive than buyers. 
 
 
 
Looking at this weekly Japanese candlestick chart of CVS, below, we are not encouraged. Prices have made what I believe is a large top pattern - a lopsided double top. The June low was broken to complete the pattern and open the way to further declines. Prices trade below the declining 40-week moving average line.
 
The weekly OBV line shows a decline from January. The MACD oscillator is bearish. 
 
 
 
In this daily Point and Figure chart of CVS, below, we can see that prices reached a downside price target in the $89-$88 area. 
 
 
 
In this weekly Point and Figure chart of CVS, below, we can see a potential downside price target in the $70 area. 
 
 
Bottom line strategy: I have no special information about what CVS is going to tell the marketplace on Tuesday about their earnings and prospects, but the charts are weak and I would avoid the long side.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Health Care Equipment & Services | Healthcare | Earnings Preview

More from Investing

Bulls Are Still Banking on This Market

James "Rev Shark" DePorre
Mar 31, 2023 4:43 PM EDT

Ironically the worst banking crisis since 2008-2009 has been a positive market catalyst.

3 High-Yield Small-Cap Stocks for High Returns

Bob Ciura
Mar 31, 2023 2:16 PM EDT

These smaller names have the potential to deliver exceptional total returns.

Could Constellation Brands Be Facing Further Declines?

Bruce Kamich
Mar 31, 2023 1:56 PM EDT

What's not yet known is if the stock is recession resistant.

IonQ Stock Has Taken a Quantum Leap

Bruce Kamich
Mar 31, 2023 1:18 PM EDT

Here's where my price targets are now.

I Have a Plan for C3.ai. But, Shhh ... Does It Know What I'm Saying?

Bruce Kamich
Mar 31, 2023 11:46 AM EDT

Here's my intelligent read on what the charts tell me about this artificial intelligence company.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:21 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How a Trader Becomes a Money Manager
  • 04:00 PM EDT CHRIS VERSACE

    AAP Podcast: This Solar Company Is a Head-Turner

    Listen to my interview with Brian Roth, CEO of sol...
  • 01:56 PM EDT PETER TCHIR

    Very Cautious

    I am very cautious here. I don't like how the c...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login